COMPARISON OF NEW GENERIC AND ORIGINAL RAMIPRIL IN PATIENTS WITH ARTERIAL HYPERTENSION AND HIGH CARDIOVASCULAR RISK

• Main Authors: S. Yu. Martsevich (Author), Yu. V. Lukina (Author), N. A. Dmitrieva (Author), O. V. Lerman (Author), S. N. Tolpygina (Author), A. A. Serazhim (Author), V. P. Voronina (Author), M. A. Maksimova (Author), L. Yu. Drozdova (Author), A. V. Zakharova (Author)
• Format: Book
• Published: Столичная издательская компания, 2016-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Aim. To compare efficacy of ramipril generic Hartil® (Egis) to original drug Tritace® in patients with arterial hypertension (HT) of 1-2 degree and high cardiovascular risk, and to evaluate target blood pressure (BP) achievement when taking each drug separately and in combination with the calcium ch...